# CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer

> **NCT05027828** · — · RECRUITING · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 100 (estimated)

## Conditions studied

- High-grade Serous Ovarian Cancer
- Circulating Tumor DNA

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05027828
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-01
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05027828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05027828, "CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05027828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*